Top compounds associated with response to ILVBL


Feature Type Standardized
Nominal ANOVA
mRNA YM-155 GDSC1000 pan-cancer AAC -0.049 0.2
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.053 0.2
mRNA MP470 GDSC1000 pan-cancer AAC 0.05 0.2
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.051 0.2
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.048 0.2
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.05 0.2
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC 0.051 0.2
mRNA Bexarotene GDSC1000 pan-cancer AAC 0.052 0.2
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.055 0.2
mRNA BRD-K29313308 CTRPv2 pan-cancer AAC 0.054 0.2
Download CSV